PROLOR Biotech For Profit

OPKO Health, Inc. is a fully-integrated healthcare company that focuses on delivering next-generation solutions for serious diseases across established global markets. The company is led by a management team with unmatched drug development experience in the industry and is dedicated to advancing proven technologies to transform patients' lives. OPKO Health has three main areas of focus: Therapies, Research, and Diagnostics. They have two marketed therapies, NGENLA� and RAYALDEE�, and are focused on advancing multispecific therapies for the treatment of serious conditions including cancers and infectious diseases. As one of the largest full-service clinical reference laboratories in the U.S., BioReference Laboratories is a leading diagnostics company that continues to deliver innovations for patients and physicians, particularly those working in specialty areas. OPKO Health has a proven track record of partnering with the world's leading organizations who seek out their scientific expertise in developing next-generation therapies.

Contact_info: 4400 Biscayne Boulevard, Miami, FL 33137, contact@opko.com, T: 305-575-4100.

Industry: Clinical Data Management
Technology: Other
Funding Status: M&A
Estimated Revenue: $ < 1M
Investors Number: 1
Headquarters: Nes Ziyona, HaMerkaz, Israel
Employee Number: Nes Ziyona, HaMerkaz, Israel
Investor Type: For Profit
Total Funding: $56.4M
Founded Date: 2001
Last Funding Type: Private Equity
Register and Claim Ownership